.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040502

« Back to Dashboard
NDA 040502 describes PYRIDOSTIGMINE BROMIDE, which is a drug marketed by Impax Labs, Ani Pharms Inc, Us Army, Alvogen Malta, Zydus Pharms Usa Inc, Corepharma, Solvay, and Impax Labs Inc, and is included in eight NDAs. It is available from six suppliers. Additional details are available on the PYRIDOSTIGMINE BROMIDE profile page.

The generic ingredient in PYRIDOSTIGMINE BROMIDE is pyridostigmine bromide. There are eleven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the pyridostigmine bromide profile page.

Summary for NDA: 040502

Tradename:
PYRIDOSTIGMINE BROMIDE
Applicant:
Impax Labs
Ingredient:
pyridostigmine bromide
Patents:0
Therapeutic Class:Antimyasthenic Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 040502

Mechanism of ActionCholinesterase Inhibitors

Suppliers and Packaging for NDA: 040502

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PYRIDOSTIGMINE BROMIDE
pyridostigmine bromide
TABLET;ORAL 040502 ANDA Impax Generics 0115-3511 0115-3511-01 100 TABLET in 1 BOTTLE (0115-3511-01)
PYRIDOSTIGMINE BROMIDE
pyridostigmine bromide
TABLET;ORAL 040502 ANDA Impax Generics 0115-3511 0115-3511-02 500 TABLET in 1 BOTTLE (0115-3511-02)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength60MG
Approval Date:Apr 24, 2003TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc